These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25794423)

  • 1. Phosphatidylinositol-3-kinase as a putative target for anticancer action of clotrimazole.
    Furtado CM; Marcondes MC; Carvalho RS; Sola-Penna M; Zancan P
    Int J Biochem Cell Biol; 2015 May; 62():132-41. PubMed ID: 25794423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomicellar Formulation of Clotrimazole Improves Its Antitumor Action toward Human Breast Cancer Cells.
    Marcondes MC; Fernandes AC; Itabaiana I; de Souza RO; Sola-Penna M; Zancan P
    PLoS One; 2015; 10(6):e0130555. PubMed ID: 26098874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells.
    Motawi TM; Sadik NA; Fahim SA; Shouman SA
    Chem Biol Interact; 2015 May; 233():147-56. PubMed ID: 25863232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clotrimazole decreases human breast cancer cells viability through alterations in cytoskeleton-associated glycolytic enzymes.
    Meira DD; Marinho-Carvalho MM; Teixeira CA; Veiga VF; Da Poian AT; Holandino C; de Freitas MS; Sola-Penna M
    Mol Genet Metab; 2005 Apr; 84(4):354-62. PubMed ID: 15781197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-apoptotic pro-survival effect of clotrimazole in a normothermic ischemia reperfusion injury animal model.
    Iannelli A; de Sousa G; Zucchini N; Saint-Paul MC; Gugenheim J; Rahmani R
    J Surg Res; 2011 Nov; 171(1):101-7. PubMed ID: 20605610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clotrimazole inhibits and modulates heterologous association of the key glycolytic enzyme 6-phosphofructo-1-kinase.
    Zancan P; Rosas AO; Marcondes MC; Marinho-Carvalho MM; Sola-Penna M
    Biochem Pharmacol; 2007 May; 73(10):1520-7. PubMed ID: 17291460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clotrimazole potentiates the inhibitory effects of ATP on the key glycolytic enzyme 6-phosphofructo-1-kinase.
    Marcondes MC; Sola-Penna M; Zancan P
    Arch Biochem Biophys; 2010 May; 497(1-2):62-7. PubMed ID: 20346906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia.
    Pereira JK; Machado-Neto JA; Lopes MR; Morini BC; Traina F; Costa FF; Saad ST; Favaro P
    Eur J Cancer; 2015 Sep; 51(14):2076-85. PubMed ID: 26238016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis.
    Furtado CM; Marcondes MC; Sola-Penna M; de Souza ML; Zancan P
    PLoS One; 2012; 7(2):e30462. PubMed ID: 22347377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clotrimazole presents anticancer properties against a mouse melanoma model acting as a PI3K inhibitor and inducing repolarization of tumor-associated macrophages.
    Ochioni AC; Imbroisi Filho R; Esteves AM; Leandro JGB; Demaria TM; do Nascimento Júnior JX; Pereira-Dutra FS; Bozza PT; Sola-Penna M; Zancan P
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166263. PubMed ID: 34481868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clotrimazole disrupts glycolysis in human breast cancer without affecting non-tumoral tissues.
    Coelho RG; Calaça Ide C; Celestrini Dde M; Correia AH; Costa MA; Sola-Penna M
    Mol Genet Metab; 2011 Aug; 103(4):394-8. PubMed ID: 21531601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detachment of glycolytic enzymes from cytoskeleton of Lewis lung carcinoma and colon adenocarcinoma cells induced by clotrimazole and its correlation to cell viability and morphology.
    Penso J; Beitner R
    Mol Genet Metab; 2002 Jul; 76(3):181-8. PubMed ID: 12126931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of clotrimazole on energy substrate uptake and carcinogenesis in intestinal epithelial cells.
    Gonçalves P; Gregório I; Araújo JR; Martel F
    Anticancer Drugs; 2012 Feb; 23(2):220-9. PubMed ID: 22075978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
    Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
    Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cathepsin S induces autophagy and apoptosis in human glioblastoma cell lines through ROS-mediated PI3K/AKT/mTOR/p70S6K and JNK signaling pathways.
    Zhang L; Wang H; Xu J; Zhu J; Ding K
    Toxicol Lett; 2014 Aug; 228(3):248-59. PubMed ID: 24875536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
    Polivka J; Janku F
    Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canonical and new generation anticancer drugs also target energy metabolism.
    Rodríguez-Enríquez S; Gallardo-Pérez JC; Hernández-Reséndiz I; Marín-Hernández A; Pacheco-Velázquez SC; López-Ramírez SY; Rumjanek FD; Moreno-Sánchez R
    Arch Toxicol; 2014 Jul; 88(7):1327-50. PubMed ID: 24792321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies.
    Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K
    Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.